DACS
BBIO icon

Dymon Asia Capital (Singapore)’s BridgeBio Pharma BBIO Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,500
Closed -$292K – 67
2021
Q4 		$292K Buy
+17,500
New +$292K 0.03% 41